Musculoskeletal Adverse Events Associated with PCSK9 Inhibitors: Disproportionality Analysis of the FDA Adverse Event Reporting System
Background. Some studies suggest that potential safety issues about PCSK9 inhibitors have not been sufficiently explored in clinical trials, including musculoskeletal adverse events (MAEs). Objective. To examine the association between use of PCSK9 inhibitors with and without concurrent statins and...
שמור ב:
Main Authors: | , , , , , |
---|---|
פורמט: | ספר |
יצא לאור: |
Hindawi-Wiley,
2022-01-01T00:00:00Z.
|
נושאים: | |
גישה מקוונת: | Connect to this object online. |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
אינטרנט
Connect to this object online.3rd Floor Main Library
סימן המיקום: |
A1234.567 |
---|---|
עותק 1 | זמין |